Chevron Corporation CVX

Risks

Catalysts

CVX is a high quality integrated major trading on a de rated forward multiple, 14.7x NTM versus a 21.7x two year average. The discount is only partly justified. The earnings base is cyclical, forward EPS growth is already flagged at -13.8%, and the FY+2 estimate of $14.45 puts the out year multiple at 15.1x, so the apparent cheapness fades on the out year. The TTM P/E of 22.1x is flattered by a $12.1b Q4 net income print; the underlying quarters ran $2.2b to $3.5b, a more honest picture of current earning power.

The structural case rests on the upstream cost curve. Hess hands Chevron 30% of Guyana Stabroek, breakevens below $40 Brent, with net production scaling toward 150-180kbpd by 2027. Combined with a Permian position holding roughly 1mbpd and a capital program of $19-22b per year, this lowers portfolio breakevens and supports the 3% dividend plus a $10-17.5b buyback even at $60-65 Brent. Balance sheet leverage at 19% debt/equity provides real capacity. Downstream is the swing factor: refining and chemicals margins sit near trough, and any capacity rationalisation in Europe or the US would lift the segment back toward mid cycle, while LNG equity at Gorgon and Wheatstone and a low carbon budget under 10% of capex keep transition spend disciplined.

The risks are the oil price, heavy insider selling, and a consensus target below spot. At $217.60 the stock sits near its 52 week high and trades at 2.2x book, +2.6 SD versus history. Fair value is $225, offering roughly 3% upside plus a 3% dividend yield. Rating Hold, with a preference to accumulate below $195.